Member Contact: Michael Kotsanis
Position: CEO & Managing Director
Industry: Biotech & Pharmaceuticals
Acrux (ASX: ACR) is a drug development company focused on commercialising topical products using its proprietary drug delivery technology. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and licensed a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Acrux will continue to innovate and bring its developed products to the market in collaboration with licensees.
For further information on Acrux, visit www.acrux.com.au